United Laboratories vests 2.53 million award shares to executives and staff under 2023 scheme

Bulletin Express11-15

Hong Kong–listed pharmaceutical group United Laboratories International Holdings Ltd. has confirmed the vesting of 2.53 million award shares on 13 November 2026, following the fulfilment of the 2025 performance targets set out in its 2023 Share Award Scheme.

The vested shares represent the first tranche of the 12.10 million award shares originally granted on 13 November 2023. Four executive directors collectively received 0.38 million shares: Chairman Tsoi Hoi Shan (0.15 million), Vice-Chairman Leung Wing Hon (0.11 million), and Executive Directors Choy Siu Chit and Zou Xian Hong (0.07 million and 0.05 million, respectively). A further 2.15 million shares were allocated to other employees across the group.

The vesting forms part of United Laboratories’ long-term incentive programme aimed at aligning management and employee interests with shareholder value creation. As of the announcement date, the board comprises four executive directors and three independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment